DIANE ANNALETT: Open Payments
NPI 1548277643 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,072 in 87 payments from 17 companies in 2025. Trend: 2023 $1,742 · 2024 $2,067 · 2025 $2,072
Food & beverage: $2,072
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $454 |
| Neurocrine BioSciences, Inc. | 19 | $413 |
| Vanda Pharmaceuticals Inc. | 8 | $216 |
| ABBVIE INC. | 11 | $190 |
| Lundbeck LLC | 6 | $151 |
| Almatica Pharma LLC | 6 | $131 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
Products named: CAPLYTA, INGREZZA, REXULTI, FANAPT, VRAYLAR, LOREEV XR, COBENFY, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
